Daxxify, a New Longer-Lasting Botox Alternative, Offered Pre-launch at Philadelphia-Area Plastic Surgery Practice
Dr. R.Brannon Claytor'sPhiladelphiaplastic surgery practice, Claytor Noone Plastic Surgery, is one of a select handful of providers to offer the new, longer-lasting neuromodulator Daxxify beginningMonday, December 12, 2022, ahead of the product's official launch in summer 2023.
BRYN MAWR, Pa.,Dec. 13, 2022/价值/——R.Brannon Claytor, MD, FACSof Claytor Noone Plastic Surgery, located inBryn Mawr, Pennsylvania,宣布新,neuromodu后使用的时间更长latorDAXXIFY™ will be available at his practice starting onMonday, December 12, 2022.
Board-certified plastic surgeon Dr. R.Brannon Claytorand his outstanding team of providers are proud to be one of the few medical spas in thePhiladelphiaarea chosen to be a part of Daxxify's early release, an honor reserved for a small group of highly respected neurotoxin injectors nationwide.
"Patients in theBryn Mawr, Main Line, and greaterPhiladelphiaareas have long trusted Claytor Noone Plastic Surgery to achieve outstanding results using the most advanced products available on the market," explains Dr. Claytor. "We are thrilled to be one of the first to offer Daxi, the latest in neuromodulating technology."
Revance AestheticsDaxxify的制造商(或“大喜”大悲),是pre-releasing their Botox-like injectable to the top 1% of neuromodulator injecting practices in the nation, making Claytor Noone Plastic Surgery part of an elite group of providers selected to offer the product ahead of its official launch in summer 2023.
Daxxify is the first FDA-approved peptide-formulated injectable neuromodulator. Similar toBotox®,Dysport®,Xeomin®, and Jeuveau®, Daxxify (daxibotulinumtoxinA) works by temporarily blocking nerve signals that cause the facial muscles to contract, relaxing treated muscles and softening expression lines. Daxxify is approved to treat glabellar lines (the frown lines between the eyebrows) and may also be used off-label to treat crow's feet, forehead lines, or above the lip to create a "lip flip" effect.
Unlike other neuromodulators currently on the market, Daxxify is formulated with a positively charged peptide to extend its anti-aging effects. Clinical trials showed thatDaxxify lasted 6-9 monthsfor some patients—which is 2-3 times longer than its competitors, making it a longer-lastingBotox alternative. Additionally, Daxxify does not contain any human or animal byproducts, a plus for those seeking a 'cleaner' Botox-type product.
Daxi treatments will be available starting onMonday, December 12, 2022with Dr. Claytor andJulie Holesh, Physician Assistant and aesthetic injector at Claytor Noone Plastic Surgery. Patients in the greaterPhiladelphiaarea are invited to schedule their appointment by calling 610-527-4833 to experience "the neuromodulator of tomorrow" today!
About Dr. R.Brannon Claytor:Dr. R.Brannon Claytor'swarmth and attention to his patients' needs make him one of thePhiladelphiaarea's favorite plastic surgeons. His knowledge of and continual training in the most advanced surgical techniques provide his patients with up-to-date, cutting-edge care that yields exceptional results. Dr. Claytor's practice, Claytor Noone Plastic Surgery, is located at 135 S Bryn Mawr Ave Suite 300,Bryn Mawr, PA19010. The office is on the Philadelphia Main Line. Dr. Claytor can be reached at (610) 527-4833 or atwww.cnplasticsurgery.com.
Media contact:Dr. R.Brannon Claytor, Claytor Noone Plastic Surgery, (610) 527-4833,[email protected],www.cnplasticsurgery.com.
SOURCE Claytor Noone Plastic Surgery
Share this article